Nurix Therapeutics (NRIX) Stock Price, Quote, News & History | Benzinga

Nurix Therapeutics Inc (NRIX) Stock Price, Quote, News & History

NRIXNASDAQ

Trade with Public

Trade with Public

$26.88

0.160.62%

At close: Aug 26, 5:00 PM EST

$26.93

0.220.82%

Pre-Market: 8:15 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$26.88

Volume / Avg.

5.00K / 1.97M

Day Range

- - -

52 Wk Range

8.20 - 28.23

Market Cap

$2.79B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.52%

Days to Cover

18.11

Recent Nurix Therapeutics Inc News

Top 3 Health Care Stocks That May Keep You Up At Night In June

Health care stocks flashing warning to momentum investors. RSI indicator shows overbought for DFTX, NRIX, GALT. Check BZ Edge Rankings for more.

Avi Kapoor

Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts ORCL PT, Needham raises APLD PT, Morgan Stanley raises AAPL PT, BTIG raises NRIX PT, GLJ Research raises CLF PT.

Avi Kapoor

Nurix Therapeutics Gains Ground As Roche Partnership Targets Growing B-Cell Blood Cancer Market

Nurix Therapeutics and Roche sign a BTK degrader partnership worth up to $2.3 billion, supporting Phase 3 plans for bexobrutideg.

Vandana Singh

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell Technology Inc (NASDAQ: MRVL) surged in pre-market trading after securing a spot in the S&P 500 index, while Real Messenger Corp (NASDAQ: RMSG) experienced a significant decline. Other gainers in pre-market trading include Dreamland Ltd (NASDAQ: TDIC), Gamehaus Holdings Inc (NASDAQ: GMHS), Nurix Therapeutics Inc (NASDAQ: NRIX), SmartKem Inc (NASDAQ: SMTK), Mountain Lake Acquisition Corp (NASDAQ: MLAC), Battalion Oil Corp (NASDAQ: BATL), Qtrex Quantum Ltd (NASDAQ: QTEX), Bone Biologics Corp (NASDAQ: BBLG), and Cullinan Therapeutics Inc (NASDAQ: CGEM).

Avi Kapoor

Meta Platforms To Rally More Than 71%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-293.70M

Investing Cash Flow (TTM)

19.99M

Financing Cash Flow (TTM)

257.20M

Free Cash Flow (TTM)

-304.53M

Capital Expenditure (TTM)

-10.82M

Net Change in Cash (TTM)

-16.51M

Analyst Trends and Forecast

1

May

8

Jun

9

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.40B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

73.17

PB Ratio (TTM)

6.93

Earnings Yield % (TTM)

-12.87%

Earnings Yield % (FWD)

-6.20%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.88

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$67.69M

Debt to Equity

0.14

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$26.88

Volume / Avg.

5.00K / 1.97M

Day Range

- - -

52 Wk Range

8.20 - 28.23

Market Cap

$2.79B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

17.52%

Days to Cover

18.11

About

Sector

Health Care

Industry

Biotechnology

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated disc...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Nurix Therapeutics (NRIX) stock?

A

You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nurix Therapeutics (NRIX) competitors?

A

Other companies in Nurix Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Nurix Therapeutics (NRIX) stock?

A

Nurix Therapeutics has a consensus price target of $32.45.

Q

What is the current price for Nurix Therapeutics (NRIX)?

A

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $26.93 last updated August 28, 2026 at 8:14 AM EDT.

Q

Does Nurix Therapeutics (NRIX) pay a dividend?

A

There are no upcoming dividends for Nurix Therapeutics.

Q

When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?

A

Nurix Therapeutics does not have any upcoming earnings scheduled.

Q

Is Nurix Therapeutics (NRIX) going to split?

A

There is no upcoming split for Nurix Therapeutics.

Q

What sector and industry does Nurix Therapeutics (NRIX) operate in?

A

Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.